David Bench - Mar 24, 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role
CFO, SVP, Treasurer and CS
Signature
/s/ David Bench
Stock symbol
ENZ
Transactions as of
Mar 24, 2022
Transactions value $
$0
Form type
4
Date filed
3/28/2022, 05:31 PM
Previous filing
Feb 15, 2022
Next filing
Apr 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENZ Common Stock, $0.01 Par Value 4.14K Mar 24, 2022 401k F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENZ Stock Option (to acquire Common Stock) Award $0 +87.5K $0.00 87.5K Mar 24, 2022 Common Stock 87.5K $2.98 Direct F2
holding ENZ Stock Option (to acquire Common Stock) 87.5K Mar 24, 2022 Common Stock 87.5K $3.36 Direct F2
holding ENZ Stock Option (to acquire Common Stock) 55.4K Mar 24, 2022 Common Stock 55.4K $2.63 Direct F2
holding ENZ Stock Option (to acquire Common Stock) 55.4K Mar 24, 2022 Common Stock 55.4K $2.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted shares granted subject the Company's discretionary matching contribution and non-elective employer contribution which vest ratable over four years of service, which began on December 23, 2019.
F2 The stock options have a five-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.